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Nodularin is a cyclic pentapeptide isolated from the cyanobacterium 
Nodularia spuntigena.] It has been found to be a potent liver toxin and 
protein phosphatase inhibitor.2 The purpose of this work was to attempt to 
establish a synthetic route to the compound, both to confirm its structure and 
to allow its structure-activity relationship and mode of action to be studied.
The structure of nodularin was elucidated and reported by Rinehart et 
al in 1988.3 It was found to be made up of D-glutamic acid, L-arginine, D- 
cryfftro-p-methylaspartic acid (MeAsp), N-methyldehydrobutyrine (MeABut), 
and (2S, 3S, 8St 9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyl-4,6- 
decadienoic acid (Adda). The structure is shown below.
D-Glu
The route chosen to attempt synthesis of the toxin was to make a
tripeptide from Thr4, MeAsp and Arg4 and a dipeptide from Adda and Glu4
and link the two fragments to complete the ring. Next the methyl group
would be introduced on the nitrogen of Thr and the MeThr would be
dehydrated to give the N-methyldehydrobutyrine unit. After ail the
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protecting groups were removed the toxin would be complete. This route is 
illustrated in Scheme 1.
Boc^-Thr can be purchased directly, as can Z4-L-Arg and Boc-D-Glu.
The fl-methylaspartic add could previously be purchased as a mixture of four 
isomers but now the erythro isomer is unavailable even as a mixture, 
although a stereoselective synthetic route has been devised by Namikoshi15 to 
prepare this isomer. The synthesis of the Adda unit was also worked out by 
Namikoshi in 1989.1 This was the source of Adda for this work. The routes 
to each fully protected amino acid are shown in Scheme 2.
Results and Discussion
The synthesis of the Thr-MeAsp-Arg unit was undertaken first. The 
starting point was the salt Boc-D.L-MeAspODCHA'ty-OBzKNO^.4'6 The benzyl 
group was introduced on the side chain by the method of 1 lamada et al7 The 
p-nitrobenzyl group was removed by zinc reduction and the cyclohexyl 
protecting group was introduced by Dhaon's method.8 The benzyl group was 
then removed by hydrogenation to give the amino acid ready to be linked 
with Arg. The overall yield for these four steps was 61%.
The synthesis of the protected Arg began with Z*l.-Arg(Mbs4)- 
OHDCHA.9 The p-nitrobenzyl group was introduced by Hamada's method8 
and the Z group was removed by hydrobromination to give the HBr salt of 
the amino acid in high yield.
These two amino acids were linked by the normal DCC4 method in 
81% yield. The product now still contained a mixture of D- and L-MeAsp,
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while D-MeAsp is the amino add needed for nodularin. These two isomers 
were found to be separable by cyano HPLC using 60:1 CHjClyiPrOH as the 
focbile phase, which give 34% L-MeAsp-L-Arg (L-L) and 39% D-MeAsp-L- 
Arg(D-L). The L-L isomer had a retention time of 15.48 min. while the D-L 
isomer was retained 18.44 min. at a flow rate of 2 mi/min. The HPLC trace is 
shown in Figure 1. AH subsequent steps were done using both isomers 
separately unless otherwise spedfied. This was done for two reasons. First, 
the L-L isomer, being of lesser importance to the final compound, was used to 
show that the reactions would in fact work as expected, and second, the L- 
MeAsp analog of nodularin is interesting to compare with native nodularin 
for biological activity. The Boc group was removed from the MeAsp by HC1 
hydrolysis and Boc-Thr added on by the DCC method in 88% yield The p- 
nitrobenzyl group was removed from the Arg by the usual zinc reduction in 
85% yield.
The Adda-Glu dipeptide was next synthesized. Boc-Adda-OMe10 was 
deprotected by base hydrolysis and linked to Glu(Bzl .'02)j-0 Bzl4 to give the 
dipeptide in 38% yield. Glu(Bzl(N02)l-0 Bzl was prepared from Boc- 
Glu(Bzl(N02)l-0 Bzl. The Boc was removed from Glu by HCl hydrolysis in 
high yield and removed from the dipeptide by the same method, again in 
high yield.
The two peptide fragments were linked to form the linear pentapeptide 
using the DCC method under normal conditions in about 80% yield. The p- 
nitrobenzyl group was removed from the Glu residue with normal zinc 
reduction. Cyclization was carried out using the pentafluorophenol active
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esterform ed  by DCC coupling with pentafluorophenol. The fee group was 
removed from the Thr residue with TFA4. Cyclization occurred 
spontaneously after removal of TFA by sodium bicarbonate. This gave the 
fully protected cydfe pent a pep tide which is only a few steps away from 
nodularin. It must stilt be methylated and dehydrated then deprotected at 
three positions to give nodularin.
F.xp.gdin^rUaj
General
Optical rotations were measured with a Jasco DIP 360 digital 
polarimeter with a sodium lamp (589 nm) using a 1-cm (0.1-mE) cell. NMR 
spectra were obtained with General Electric QE-300 (300 MHz) and GN 500 (500 
MHz) spectrometer. High and low resolution fast atom bombardment (FAB) 
mass spectra were measured by Furong Sun on a VG analytical ZAB SE (low 
resolution) and a VG 70-SE4F (high resolution) spectrometer. Gravity 
columns were prepared with Kieselgel 60 (EM reagent, 240-400 mesh) or 
Sephadex Ell-20 (Pharmacia), TEC plates were precoated Kiesselgel 60. High 
performance liquid chromatography (HPLC) was performed on a system 
comprised of a Beckman Model 114M pump and a Beckman 153 UV detector 
at a wave length of 254 nm. An Alltech Econosil CN column (250 mm x 10 
mm, 10 pm particle size) was used. All authentic samples were obtained 
from Dr. Namikoshi.
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5Boc-MeAsp-OChx ^ L-ArqfMbsl-OBzKNOj) (1)
Boc-D,L-MeAsp-OChx4 (401.0 mg, 1.219 mmol) was mixed with H-L- 
Arg(Mbs)-OBzl(NOi) HBr (819.1 mg, 1.463 mmol) and HOBt4 (246.8 mg, 1.829 
mmol) in 5 mL of DMF4. The solution was cooled in an ice bath and NMM4 
(161 pL, 1.463 mmol) was added. DCC (276.7 mg, 1.343 mmol) was added next 
and the mixture was stirred for 1 h. The solution was then allowed to warm 
to room temperature and stirred overnight. The solution was filtered and 
diluted with ethyl acetate (250 ml). This solution was washed with 50 ml each 
of 5% NaHCOj, 10% citric acid and brine. It was then dried over Na^ 04  and 
evaporated. The residue was dissolved in methanol and purified by LH-20 
(MeOH) column chromatography to give 778.6 mg, 0.986 mmol (81 % yield). 
The product was compared with an authentic sample by TLC (10% 
MeOH/CHClj): M d20 5.12° (c 1.01, CHCW; FABMS m/z 791 (M + H)+, 691, 
621.
Anal. CalcdforC36H5lN6 0 l 2S: 791.3286 (M + H). Found: 791.3275 
(HRFABMS).
Boc-L-MeAsp-OChxk-Arg(Mbs)-OBzl(NO: ) (ID and Boc-D-
MeAsp-OChx k-Arg(Mbs)-OBzl(NQ2) (Id)
The D and L isomers of MeAsp in this dipeptide were separated by 
HPLC (cyano column, 60:1 CHjClyiPrOH, 2 mL/min). The L isomer had a 
retention time of 15.5 min. and (alo20 13.57° (c 0.50, CHCI3), while the D 
isomer had a retention time of 18.4 min. and a calculated [alo20 -8.46°.
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H-'J-MeAs'p-OChx LL-Arg(Mhsi-OBzKNO..) HC1 (2d)
HC1 was bubbled through a mixture of dioxane (2 ml.) and anisole (0.2 
mL) for about 5 min. and 2.0 mL of this solution was added to 91.9 mg of the 
dipeptide. The mixture was stirred at room temperature for 2 h then 
evaporated to dryness. The residue was triturated with Et20 and used 
without further purification: (alo20 11.22° (c 0.52, CHCI.t); FABMS m/z 691 
(M + H)+, 570.
Anal. CalcdforC3iH43N60ioS: 691.2761 (M + H). Found: 691.2777 
(HRFABMS).
H-L-MeAsp-OChx kL-Arg(Mbs)-OBzl(NO: ) HC1 (21)
The HC1 salt of the L isomer of the dipeptide was made by the same 
procedure as the salt of the D isomer: lalp20 -7.95° (c 0.44, MeOl l); FABMS 
m/z 691 (M + H)+, 570.
Anal. Calcd forC3iH43N6 0 ioS: 691.2761 (M + H). Found: 691.2764 
(HRFABMS).
Boc-Thr-L-MeAsp-OChxl-L-ArgfMbsl-OBzKNOJ  Q})
Compound 21 (151.3 mg, 0.2083 mmol) was added to Boc-Thr (91.4 mg, 
0.4166 mmol) and HOBt (42.0 mg, 0.311 mmol) in 2:1 CHtC^DMF. This 
mixture was cooled in an ice bath and NMM (25 gL, 0.229 mmol) was added. 
DCC (47.7 mg, 0.232 mmol) was added next and the mixture was stirred for 1 
h. The solution was then allowed to warm to room temperature and stirred 
overnight, filtered and diluted with ethyl acetate (40 mL). This solution was
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washed with 15 mL each of 5% NaHCOi 10% citric acid and brine, then dried 
over Na$ 0 4  and evaporated. The residue was dissolved in methanol and 
purified by LH-20 (MeOH) column chromatography to give 116.5 mg (0.1308 
mmol) of product and mixed fractions that were purified by silica gel column. 
Both fractions were combined to give 156.3mg (175.5 mmol) total of product 
(84% yield): [altj20 46.75° (c 0.11, CHCI3); ’ H-NMR, Figure 2; FABMf* m/z 892 
(M + H)+, 792, 722.
Anal. Calcd for C40H58N7O14S: 892.3762 (M + H). Found: 892.3749 
(HRFABMS).
Boc-Thr-D-MeAsp-OChx l  L-Arg(Mbs)-OBzl(NO-,) (3d)
Crude compound 2d was added to Boc-Thr (50.9 mg, 0.2326 mmol) and 
HOBt (23.6mg, 0.174 mmol) in 2:1 CHaC^iDMF. This mixture was cooled in 
an ice bath and NMM (14 pL, 0.128 mmol) was added. DCC (26.4 mg, 0.128 
mmol) was added next and the mixture was stirred for 1 h. The solution was 
then allowed to warm to room temperature and stirred overnight, filtered 
and diluted with ethyl acetate (20 mL). This solution was washed with 5 mL 
each of 5% NaHCOi 10% citric acid and brine, then dried over Na£ 0 4  and 
evaporated. The residue was dissolved in methanol and purified by LH-20 
(MeOH) column chromatography to give 91.8 mg, 0.103 mmol (89% yield) of 
product: [oJd20 38.22° (c 0.29, CHCI3); >H-NMR, Figure 3; FABMS m/z 892 
(M + H)+, 792, 722.
Anal. Calcd for C40H58N7O14S: 892.3762 (M + H). Found: 892.3782 
(HRFABMS).
8Boc-Thr-L-MeAsp-OChx l  l.-Arg(Mbs)-OH (41)
Compound 31 (92.2 mg, 0.i035 mmol) was dissolved in 1 mL of 90% 
acetic acid, and activated zinc (338.3 mg, 5.175 mmol) was added. The solution 
was stirred in an ice bath for 1 1/2 h, filtered and evaporated. The resulting 
residue was dissolved in 10% citric acid (5mL) and extracted with EtOAc. The 
organic layer was dried over Na2SC>4 and evaporated. The residue was 
dissolved in methanol and purified by LH-20 (MeOH) column 
chromatograph r to give 71.8 mg (0.095 mmol) of product (85% yield): (alp20 - 
31.67° (c 0.12, CHCI3); !H-NMR, Figure 4; FABMS w/z 757 (M + H)+, 657, 
587.
Anal. Calcd for C33H53N6O 12S: 757.3442 (M + H). Found: 757.3439 
(HRFABMS).
Boc-Thr-D-MeAsp-OChx >-L-Arg(Mbs)-OH (M)
Compound 3d (87.4 mg, 0.098 mmol) was dissolved in 1 mL of 90% 
acetic acid. Activated zinc (320.6 mg, 4.90 mmol) was added. The solution 
was stirred in an ice bath for 1 1/2 h, filtered and evaporated. The resulting 
residue was dissolved in 10% citric acid (5 mL) and extracted with EtOAc. The 
organic layer was dried over Na^©4 and evaporated. The residue was 
dissolved in methanol and purified by LH-20 (MeOH) column 
chromatography to give 55.7 mg (0.074 mmol) of product (84% yield): (alp20 
7.60° (c 0.25, CHCI3); 1H-NMR, Figure 5; FABMS m/z 757 (M + H)+, 657, 587.
9Anal. Calcd for C33H53N6O12S: 757.3442 (M + H). Found: 757.3461 
(HRFABMS).
^ A .r g (Mbs)-QBzl(NQ2) (5)
Z-L-Arg(Mbs)-OHDCHA (131.8 mg, 0.20 mmol) was dissolved in 2 mL 
of DMF and 87.1 mg (0.41b mmol) of Bzl(NC>2)Br was added, followed by 60.0 
mg (0.60 mmol) of KHCO3. The solution was stirred overnight at room 
temperature, diluted with 10 mL of 1:1 benzene:EtOAc and washed with 5 mL 
of water twice followed by 5 mL each of 5% Na2SC>* and brine. The solution 
was then dried over Na2504 and evaporated. The residue was purified on a 
silica column (95:5 CHCl^MeOH) to give 108.4 mg, 0.177 mmol (88% yield) of 
product, compared by TLC (95:5 CHCl^MeOH) with an authentic sample: 
(alp20 15.88° (c 0.53, CHCI3); FABMS miz 614 (M + H)+.
Anal. Calcd for C28H32N5O9S: 614.1921 (M + H). Found: 614.1912 
(HRFABMS).
H-L"Arg(Mbs)»OBzl(NOg) H Br
Compound 5 (1 1666 g, 1.903 mmol) was dissolved in 30% HBr in acetic 
acid. This solution was allowed to sit at room temperature for 30 min. The 
solvent was then evaporated and the residue was washed with Et20  to give 
1.2205 g. This was characterized by FABMS and used without further 
purification: FABMS m/z 480 (M + H)+.
Anal. Calcd for C20H26N5O7S: 480.1553 (M + H). Found: 480.1560
(HRFABMS).
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Boc-MeAsp(Bzl)-OBzl(NCty (6)
Boc-MeAsp-OBzl(N02) DCHA (1.1262 g, 2.000mmol) was dissolved in 
10 mL of DMF and 4757 pL (4.00 mmol) of BzlBr was added to this solution 
followed by 300 mg (6.00 mmol) of KHCO3. This solution was allowed to 
stand overnight at room temperatuie. The solution was diluted with 30 mL 
of 1:1 benzene:EtOAc and washed with 10 mL of water twice, followed by 10 
mL each of 5% Na2SOs and brine. The solution was then dried over Na2SC>4 
and evaporated. The product was purified by silica column (4:1 
hexane.-acetone) to give 953.0 mg of product, which was compared by TLC (4:1 
hexane.acetone) with an authentic sample and was used without further 
purification: [<x)d20 37.50° (c 0.26, CHCI3); FABMS m/z 473 (M + H)+, 417, 373.
Anal. Calcd for C24H29N2O8: 473.1924 (M + H). Found: 473.1917 
(HRFABMS).
Boc-MeAsp(Bzl)-OH (7)
Crude compound 6 was dissolved in 2.5 mL of 90% acetic acid and 
cooled in an ice bath then 4.0 g (61.2 mmol) of activated Zn was added and the 
solution was allowed to sit in an ice bath for 1 h. The mixture was then 
filtered and evaporated. The residue was dissolved in 10% citric acid and 
extracted with EtOAc. The EtOAc extract was dried over Na2SC>4 and 
evaporated to give 681.1 mg of product which was compared by TLC with an 
authentic sample.
II
Boc-MeAsp(Bzl)-OChx (8)
Crude compound 7 was dissolved in 6 mL of CH2CI2. Cyclohexanol 
(665 pL, 6.063 mmol) and DMAP (24.6 mg, 0.202 mmol) were added to the 
solution. The solution was cooled in an ice bath and DCC (458.0 mg, 2.223 
mmoli was added. The mixture was kept in an ice bath for 2 h., then filtered. 
The filtrate was evaporated and the residue purified on a silica column (95:5 
hexane:acetone) to give 542.2mg (1.294 mmol) of product (65% yield from Boc- 
MeAsp-0Bzl(N02) DCHA, 3 steps). The product was compared with an 
authentic sample by TLC (4:1 hexane:acetone): [alp20 -0.25° (c 0.34, CHCI3); 
FABMS m/z 420 (M + H)+, 364, 320.
Anal. Calcd for C23H34N1O6: 420.2386 (M + H). Found: 420.2368 
(HRFABMS).
Boc-MeAsp-OChx (9)
Crude compound 8 dissolved in EtOAc (20 mL) and mixed with 5% Pd- 
C (500 mg) was stirred vigorously in an H2 atmosphere for 1 h at room 
temperature. The mixture was then filtered and evaporated to give 401.1 mg 
(1.219 mmol) of product (94% yield) which was compare with an authentic 
sample by TLC: FABMS m/z 330 (M + H)+, 274, 230.
Boc-(S.S.S.S)-Adda-OH (10)
A 1:1 MeOH:Acetone (6 mL) solution was used to dissolve Boc- 
(S.S.S.S)-Adda-OMe (127.7mg, 0.2870 mmol), cooled in an ice bath and mixed 
with 3 mL of 1M NaOH (3 mmol). This solution was kept in an ice bath and
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stirred for 3 h and was then allowed to warm to room temperature and stirred 
for another 3 h. Then 15 mL of water was added and the solution was 
acidified with saturated KHSO4, and extracted with EtOAc and the organic 
layer was dried over Na2SC>4 and evaporated. The resulting residue was 
purified on silica gel (95:5 CHCljMeOH) resulting in some purified 
compound as well as a mixed fraction which was purified on silica again (9:1 
CHClyMeOH) to give 96 mg (0.2227 mmol) of product overall (78% yield): 
(alo20 -2.55° (c 0.14, CHCI3); 'H-NMR, Figure 6; FABMS m/z 132 (M + H)+ 
376,332.
Anil. Calcd forC25H38N l0 5 : 432.2750 (M + H). Found: 432.2752 
(HRFABMS).
H-P-Glu(Bzl(NQ2))-OB2l HCl (H)
Hydrogen chloride gas was bubbled into a mixture of 5 mL of dioxane 
and 0.5 mL of anisole for 5 min. Boc-D-Glu(OBzl(N02»*OBzl (127.1 mg, 0.2693 
mmol) was added and the solution was allowed to sit at room temperature 
for 1 h. It was then evaporated and triturated with Et20 to give 87.5 mg (0.214 
mmol, 80% yield) of white solid. This was characterized by FABMS and used 
without further purification: (alo20 -4.47° (c 0.41, MeOH); FABMS mlz 373 
(M + H)+, 309, 275.
Anal. Calcd for C19H21N2O6: 373.1400 (M + H). Found: 373 1388
(HRFABMS).
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Boc-(S,S,S,S)-Adda-D-Glu(OBzl(NO^)-OBzl (12)
Compound 10 (96.0 mg, 0.2227 mmol) was mixed with compound i l  
(109.2 mg, 0.2672 mmol) and 45.1 mg (0.3341mmol) of HOBt in 2 mL of 1:4 
DMF.CH2CI2. This solution was cooled in an ice bath and stirred, then 26.9 gL 
(0.2450 mmol) of NMM, followed by 50.5 mg (0.2450 mmol) of DCC, were 
added. The mixture was stirred in an ice bath for 1 h then warmed to room 
temperature and stirred overnight, diluted with ethyl acetate (15 mL) and 
filtered. This solution was washed with 5 mL each of 10% citric acid, 5% 
NaHCOs and brine, dried over Na2S04 and evaporated. The residue was 
dissolved in methanol and purified by LH-20 (MeOH) column 
chromatography to give 58.2 mg (0.085 mmol) of product (38% yield)- [a)o2l) 
24.22° (c 0.32, CHCli); Hl-NMR, Figure 7; FABMS m/z 786 (M + H>+, 686.
Anal. Calcd for C44H56N3O 10: 786.3966 (M + I I). Found: 786.3977 
(HRFABMS).
H-(S.S.S.S)-Adda-D-Glu(QBzl(NO;))-OBzl TFA (13)
Anisole (0.1 mL) was added to compound 12 (58.2 mg, 0.085 mmol), the 
solution was then cooled in an ice bath and 2.0 ml. of TFA was added. This 
solution was allowed to sit in an ice bath for 1 h. then evaporated and 
triturated with petroleum ether to give 67.7 mg of product: [ali>20 20.06° (c 
0.27, MeOH); FABMS m/z 686 (M + H)+, 535.
Anal. Calcd for C39H48N3O8: 686.3441 (M + H). Found: 686.3459
(HRFABMS).
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H-(R.S.S,S)-Adda-P-Glu(OBzl(NO?))-OBzlTFAa5)
Anisole (0.1 mL) was added to Boc-(R,S,S,S)-Adda-D-Glu(OBzl(N02»* 
OBzl (14) (61.5 mg, 0.078 mmol).9 This solution was then cooled in an ice bath 
and 2.0 mL of TFA was added. The solution was allowed to sit on an ice bath 
for 1 h then evaporated and triturated with petroleum ether to give 89.2 mg 
of product: FABMS m/z 686 (M + H)+, 535, 456.
Anal. Calcd for C39H48N3O8: 686.3441 (M + H). Found: 686.3466 
(HRFABMS).
Boc-Thr-L-MeAsp-OChx k-Arg(Mbs)-(R.S.S.S)-Adda-D-GlulBzl(NCUl- 
OBzl (16)
Compound H  (unpurified) was mixed with compound 41 (71.8 mg, 
0.095 mmol) and 15.8 mg (0.117 mmol) of HOBt in 2 mL of 1:4 DMF:CIl2Cl2 
and the mixture was cooled in an ice bath and stirred. NMM (9.4 gL, 0.0858 
mmol), followed by 17.7 mg (0.0858 mmol) of DCC, were added. The mixture 
was stirred in an ice bath for 1 h, then warmed to room temperature, stirred 
overnight, diluted with ethyl acetate (50 ml.) and filtered. The filtrate was 
washed with 10 mL each of water and brine, then dried over Na25C and 
evaporated. The residue was dissolved in methanol and purified by IT 1*20 
(MeOH) column chromatography to give 90.5 mg (0.0636 mmol) of product 
(81% yield from compound 14): [alp20 3.30° (c 0.13, CHCI3); Hl-NMR, Figure 
8; FABMS m/z 1425 (M + H)+, 1325, 1255.
Anal. Calcd for C72H97N9O19S: 1424.6700 (M + H). Found:12
(HRFABMS).
Boc-Thr-P-MeAsp-OChx LL-Ary(Mbs)-(S.S.S.S)-Adda-D-GlulBzl(NO: )l-
QBzl (17)
Compound 12 (47.4 mg, 0.0593 mmol) was mixed with compound id  
(49.3 mg, 0.0652 mmol) and 12.0 mg (0.0890 mmol) of HOBt in 0.6 mL of 1:2 
DMFiCH^Cl  ^ and the solution was cooled on an ice bath, and stirred while 7 
gL (0.065 mmol) NMM, followed by 13.4 mg (0.0652 mmol) DCC, were added. 
The mixture was stirred on an ice bath for 1 h, then warmed to room 
temperature, stirred overnight, diluted with ethyl acetate (50 ml.) and filtered. 
This solution was washed with 5 nL each of water and brine, dried over 
Na2S04 and evaporated. The residue was dissolved in methanol and purified 
by LH-20 (MeOH) column chromatography to give 64.4 mg (0.0453 mmol) of 
product (76% yield): [a|p20 -28.20° (r 0 .3 9 ,0 1 0 *); Ul-NMR, Figure 9;
FABMS m/z 1424 (M + II)4, 1324, 1254.
Anal. Calcd for C72H98* \ O19S: 1424.6700 (M + I I). Found: 1424.6715 
(HRFABMS).
Boc-Thr-L-McAsp-OChx l-L-Arp(Mbs)-(R S.S.Sl-Adda-D-Glu-OB/1 (18)
Compound 16 (76.9 mg, 0.0541 mmol) was dissolved in 1.0 ml. of 90'# 
acetic acid and cooled in an ice bath, then 176.8 mg (2.705 mmol) of activated 
Zn was added. The mixture was stirred in an ice bath for 1 h., filtered and 
evaporated. The residue was dissolved in 10% citric acid and extracted with 
EtOAc. The EtOAc extract was dried over Na2SC>4 and evaporated, and the 
residue was triturated with EI2O and purified by IA1-20 (MeOH) column 
chromatography to give 55.4mg (0.043 mmol) of product (80% yield): (alp20 - 
4.08° (c 0.14, CHCI3); 1H-NMR, Figure 10; FABMS m/z 1289 (M + H)+, 1119.
15
16
Anal. Calcd for C65H93N8O17S: 1289.6379 (M + H). Found: 
1287.943815 (HRFABMS).
Boc-Thr-D-MeAsp-OChx LL-Arg(MbsHS,S,S,S)-Adda-D-Glu-OB2l (19)
Compound 17 (65.8 mg, 0.046 mmol) dissolved in 1.0 mL of 90% acetic 
acid was cooled on an ice bath, then 151.1 mg (2.312 mmol) of activated Zn 
was added and this solution was stirred in an ice bath for 1 h., filtered and 
evaporated. The residue was dissolved in 10% citric acid and extracted with 
EtOAc. The EtOAc extract was dried over Na2SC>4 and evaporated, and the 
residue triturated with Et20 and purified by LH-20 (MeOH) column 
chromatography to give 17.6 mg (0.0137 mmol) of product (30% yield): lalo20 
-1.72° (c 0.87, CHCI3); *H-NMR, Figure 11; FABMS m/z 1288 (M + H)+, 1189, 
1120.
Anal. Calcd for C65H93N8O17S: 1289.6379 (M + H). Found: 
1287.9414*3 (HRFABMS). *1
L-Thr-L-MeAsD OChx LL-Ar? (Mbs)-(R.S.S.S)-Adda-D-Glu-OBzl (20)
Compound 18 (20.0 mg, 0.0155 mmol) mixed with pentafluorophenol 
(3.4 mg, 0.0186 mmol) and dissolved in CHjCl&was cooled in an ice bath and 
stirred. DCC (3.5 mg, 0.0171 mmol) was added and the mixture was stirred for
1 h. in an ice bath, allowed to warm to room temperature and stirred 
overnight, then filtered to remove the DCU4 formed. The solution was put 
back in an ice bath and stirred, TFA (0.1 mL) \ as added and the solution was 
stirred for 1 h., then evaporated. The residue was dissolved in 0.5 mL of
17
CH2CI2 and diluted with 5.0 mL of CHCb, then 0.5 mL of 1 N NaHCC>3 was 
added and the solution was shaken vigorously for 5 min. and allowed to sit 
for 1 h. The organic layer was separated, dried over Na2S04 and evaporated. 
This residue was purified by preparative TLC (94:6 CHCljMeOH) to give 1.7 
mg (0.00145 mmol) of product (9% yield): (alp20 6.35° (f 0.52, CHCI3); 'H- 
NMR, Figure 12; FABMS mlz 1172 (M + H)+, 1139.
Anal. Calcd forC60Hg3N8O i4S: 1171.5750 (M + H). Found: 1171.5779 
(HRFABMS). 1*
L-Thr-D-MeAsp-OChx LL-ArgfMbsl-f.S.S.S.Sl-Adda-l^Glu-OBzl (21.)
Compound 19 (15.7 mg, 0.0122 mmol) mixed with pentafluorophenol 
(2.7 mg, 0.0146 mmol) and dissolved in CH2CI2 was cooled in an ice bath and 
stirred. DCC (2.8 mg, 0.0134 mmol) was added, and the mixture was stirred for
1 h. in an ice bath, allowed to warm to room temperature and stirred
overnight, then filtered to remove the DCU formed. The solution was put
back in an ice bath and stirred, TFA (0.7 ml.) was added and the solution was
stirred for 1 h., then evaporated. The residue was dissolved in 0.5 mL of
CHsChand diluted with 4.0 mL of CHCI3, then 0.25 mL of 1 N Nal lCO  ^was
added and the solution was shaken vigorously for 5 min. and allowed to sit
for 1 h. The organic layer was separated, dried over Na2SC>4 and evaporated.
This residue was purified by preparative TLC (92:8 CHCl^MeOH) to give 2.1
mg (0.0018 mmol) of product (15% yield): [a]p20 -11.31° (c 0.42, CHCI3); 1 LI­
NN®, Figure 13; FABMS m/z 1172 (M + H)+, 1139.
18
Anal. Calcd for C6OH83N8O14S: 1171.5749 (M + H). Found: 1171.5747 
(HRFABMS).
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Boc-McAsp-OChx + H-L-Arg(Mbs)-OBzl(N02)
I DCC, HOBt, CHjCIj  
1 (81% )
Boc-McAsp-OChjr'L-Arg(Mbs)-OBzl(NOj)
(
HCI/dioxane 
(96%)
i------------1
H-MeAsp-OChx *-L-Arg(Mbs)-0BzI(N02)
+ Boc-Thr-OH
1
DCC, HOBt, CH2C12 
(89%)
21
Boc-Adda-OMe 
| NaOt l
H-D-Glu|Bzl(N02)K)Bzl + Boc-Adda-OH
I DCC, HOBt, CH2CI2 
I  (38% from Me ester)
Boc-Thr-Me Asp-OChx l-L-Arg(Mbs)-0Bzl(N02) Boc-Adda-D-Glu|Bzl(N02)l-OBzl
I Zn/AcOH
(85%) ITFA
Boc-Th r-M e A sp-O C h^ L- A rg( M bs)-OH ♦ H-Adda-P-Glu|Bzl(N02)|-OBzl
DCC, HOBt 
(82%, 2 steps)
Boc-Thr-MeA9p-OChx"l-L-Arg(Mbs)-Adda«D-Clu|Bzl(N02)|-OBzl
Zn/AcOH
(80%)
t... ...* 1 l
Boc-Thr-MeAsp-OChx ^L-Arg(Mbs)-Adda-D-Glu*OBzl
C6F5OH/DCC
Boc-Thr-MoAsp-OCh7L.L.Arg(Mbs)-Adda«D-Glu(CyV-OBzl
1) TFA
2) NaHC03 
* (9%, 3 steps)
Scheme
■------------- - i
pThr-MeAsp-OChx L L-Arg(Mbs)-Adda-P-Ciu-OBzl
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(A) D,I.-Threonine (stable precursor for N-methyldehydrobutyrino)
D,L-Thr i Boc).?? -^  Boc-Thr-OH 
Et3N (92%)
(B) D,L-Eryt/iro-|}-methylaspartic acid
D,L-Eryffiro-MeAsp B° C9 .N , Boc-MeAsp-OHy , ^  Boc-MeAsp-O
Et3N {98%) K THF (91%)
Bz^ g j 9 *  Boc-MeAsp-OBzl(NOj) DCHA 
DCHA (51%)
BzlBr- »  Boc-MeAsp(Bzl)-OBzl(N02) ^ Zn^ASPH,.
KHCOi n) cyclohexanol
DCC, DMAP'
Boc-MeAsp(Bzl)-OChx H2/pd-C Boc. MeAsp.o c h x  
(65%, two steps) EtOAc (94%)
(C) L-Arginine 
Z.C1 i) Mbs-Cl. NaOM
L' Arg N aH cd, Z* ^ g ' OH ii) DCHA
Z-L-Arg(Mbs)-OBzl(N02)KHC0 3 (g8%)
HBr/Ac0HHL-Arg(Mbs)0Bzl(N02)
(98%)
(D) D-Glutamic add
D-Glu Boc-D-Glu-OH Boc-D-6lu-0
EUN iaaor\ THF lanoL\
Z*L-Arg(Mbs)-OH DCHA
(92%)
Boc-D-Glu-OBzrDCHA Boc-D-GlulBzl(N02)]-OBzl
HCl/dioxane
H-D-Glu[Bzl(N02)l-OBzl
(80%)
Scheme 2
L-Arg(Mbs)-OBz!(NQ2)
Boc-L-MeAsp-OChx
L-Arg(Mbs)~0 Bzl(N02)
Boc-D-MeAsp-OChx
Figure 1. HPLC trace of separation of the diastereomers of the dipeptide. 
(Cyano column, 60:1 CM2C12:iPrOH, 2 ml/min, 15 cm/min.)
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®>
4tA.SC MIOTM .
*ca rue -
M C T C L ( T » t f  -  
■O OF AC4S -
» t »  u u  -IM IMaOM - 
V S «  M ( |  -
4 M  UM C
St
< j # st e  
1 •* sec
s*#
<4*44** *1 
»  4»!
waUH tma • le t
s n e  t«oiM» 4634 mj
«*!«•  *  * 3  •«
41. o r SCM.C:
N  94 mz ■ »
3*43 444*/'C»i 
* 44
T o -  ; ;  * * •
K>
f
Figure 2. ^H-NMR Spectrum for Compound 21
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Figure 4. 'H -N M R Spectrum for Compound 41
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Figure 9. l H-NMR Spectrum  for Compound 17
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Figure 13. *H-NMR Spectrum for Compound 21
